Impact of reduced mycophenolate exposure on chronic lung allograft dysfunction incidence after lung transplant

Impact of reduced mycophenolate exposure on chronic lung allograft dysfunction incidence after lung transplant

Background: Mycophenolate mofetil (MMF) is a key immunosuppression agent for lung transplant recipients (LTR); however, the side effects often lead to dose modifications. Kidney transplant literature has shown reductions in MMF dosing led to an increased incidence of rejection, but data are limited...

Full description

Bibliographic Details
Main Authors: Kaitlyn Grieves, PharmD, Brian C. Keller, MD, PhD, Georgina Waldman, PharmD, BCTXP, Jacqueline E. Clark, PharmD, BCPS, BCTXP
Format: Article
Language:English
Published: Elsevier 2024-11-01
Series:JHLT Open
Subjects:
lung transplant
mycophenolate
rejection
CLAD
immunosuppression
Online Access:http://www.sciencedirect.com/science/article/pii/S2950133424001058

Internet

http://www.sciencedirect.com/science/article/pii/S2950133424001058

Similar Items